Chemours Co — Director's Dealing 2022

Oct 7, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2022-10-01

Reporting Person: Wellman Kristine M (SVP, GC & Corp. Secretary)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	23480.8165	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$25.98	2032-03-01	Common Stock (15925)		Direct
Stock Option (Right to Buy)	$24.01	2031-03-01	Common Stock (6390)		Direct
Stock Option (Right to Buy)	$14.43	2030-03-02	Common Stock (11140)		Direct
Stock Option (Right to Buy)	$38.02	2029-03-01	Common Stock (4006)		Direct
Stock Option (Right to Buy)	$48.53	2028-03-01	Common Stock (2554)		Direct
Stock Option (Right to Buy)	$34.72	2027-03-01	Common Stock (5936)		Direct

Footnotes

F1: Includes directly owned shares, restricted stock units and dividend equivalent units.

F2: Options vest in three equal installments beginning on March 1, 2023.

F3: Options vest in three equal installments beginning on March 1, 2022.

F4: 50% of the option balance is vested and 50% will vest on March 2, 2023.

F5: Options are fully vested.